vTv Therapeutics Inc. Cl A | Ownership
Companies that own vTv Therapeutics Inc. Cl A
The Vanguard Group, Inc.
117,012
1.02%
-162,215
0%
06/30/2018
Apo Asset Management GmbH
99,000
0.87%
0
0%
06/29/2018
Deutsche Bank Securities, Inc.
95,376
0.83%
95,376
0%
06/30/2018
A.R.T. Advisors LLC
70,257
0.61%
70,257
0%
06/30/2018
Bridgeway Capital Management, Inc.
68,800
0.6%
-6,200
0%
06/30/2018
Northern Trust Investments, Inc.
52,590
0.46%
-43,610
0%
06/30/2018
Geode Capital Management LLC
51,205
0.45%
7,514
0%
06/30/2018
BlackRock Fund Advisors
49,899
0.44%
-267,619
0%
06/30/2018
C WorldWide Asset Management Fondsmæglerselskab A/S
48,185
0.42%
-49,778
0%
06/30/2018
Goldman Sachs & Co. LLC (Private Banking)
45,518
0.4%
45,518
0%
06/30/2018
| Address |
4170 Mendenhall Oaks Parkway
High Point North Carolina 27265
United States
|
|
Employees
|
- |
| Website |
http://www.vtvtherapeutics.com |
| Updated |
07/08/2019 |
| vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical holding company. The firm engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. |
